Table 6 Proportion of symptomatic TEs according to concomitant medication
% (n/N) | (95% CI) | ||
|---|---|---|---|
Concomitant Medication | Nadroparin | Placebo | Relative risk |
Steroids | 2.4 (14/586) | 4.0 (12/300) | 0.60 (0.28-1.28) |
G-CSF | 0.0 (0/116) | 1.7 (1/59) | ND |
NSAID | 1.2 (1/86) | 0.0 (0/49) | ND |
Erythropoietin | 3.5 (2/57) | 3.0 (1/33) | 1.16 (0.11-12.29) |
Blood and related products | 0.0 (0/21) | 6.7 (1/15) | ND |
Aspirin | 5.9 (1/17) | 25.0 (2/8) | 0.24 (0.02-2.23) |